Vestmark Advisory Solutions, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1736982 Wakefield, MA

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,401,717

-$40,801 QoQ

Shares Held

2,248

+20.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#586

of 1,322 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 39% Shared 0% None 61%

Healthcare · as of Jun 30, 2026

Vestmark Advisory Solutions, Inc. holds $64,583,105 across 33 Biotechnology names. REGN ranks #17 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	242,266	$13,213,187
2	NTLA	Intellia Therapeutics, Inc.	532,817	$9,015,263
3	BEAM	Beam Therapeutics Inc.	164,164	$5,634,108
4	VRTX	Vertex Pharmaceuticals Inc / Ma	7,762	$3,855,617
5	TECH	BIO-TECHNE Corp	44,928	$3,174,163
6	RXRX	Recursion Pharmaceuticals, Inc.	708,858	$2,601,507
7	ALNY	Alnylam Pharmaceuticals, Inc.	8,217	$2,473,562
8	PRAX	Praxis Precision Medicines, Inc.	6,681	$2,236,731

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,401,717	2,248	+20.4%	Shares	Other	2026-08-14
2026-03-31	$1,442,518	1,867	+43.6%	Shares	Other	2026-05-15
2025-12-31	$1,003,430	1,300	-30.5%	Shares	Sole	2026-02-06
2024-06-30	$1,966,477	1,871	+24.7%	Shares	Sole	2024-08-12
2024-03-31	$1,443,735	1,500	-22.5%	Shares	Sole	2024-05-15
2023-12-31	$1,699,491	1,935	+236.5%	Shares	Sole	2024-02-06
2023-06-30	$413,160	575	+28.1%	Shares	Sole	2023-08-07
2023-03-31	$368,929	449	+57.5%	Shares	Sole	2023-05-09
2022-12-31	$205,624	285	-55.1%	Shares	Sole	2023-01-20
2022-03-31	$443,496	635	+13.2%	Shares	Sole	2022-04-27
2021-12-31	$354,282	561	+20.9%	Shares	Sole	2022-01-31
2021-09-30	$280,803	464	-60.9%	Shares	Sole	2021-11-15
2021-03-31	$562,090	1,188	+101.7%	Shares	Sole	2021-05-10
2020-12-31	$284,551	589	—	Shares	Sole	2021-02-04
No filing history on record for this holder in this stock.